Combined with the results described in Sect. Influences of YGS on metastatic relapse of CRC stem cells, we hypothesized that YGS might inhibit tumor immune escape by sensitizing CRC stem cells via the NF-κB signaling pathway by targeting TLR4, which was subsequently verified in vitro and in vivo. This evidence concerns the gene TLR4 and colorectal carcinoma.